Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B de Muralt

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Anticancer Research|January 1, 1983
Reactivity of antiglioma monoclonal antibodies for a large panel of cultured gliomas and other neuroectoderm derived tumorsB de Muralt, N de Tribolet, A C Diserens, et al.
Respiratory Medicine|June 8, 2001
Is continuous transcutaneous monitoring of PCO2 (TcPCO2) over 8 h reliable in adults?J P Janssens, E Perrin, I Bennani, et al.
European Journal of Cancer & Clinical Oncology|February 1, 1985
Phenotyping of 60 cultured human gliomas and 34 other neuroectodermal tumors by means of monoclonal antibodies against glioma, melanoma and HLA-DR antigensB de Muralt, N de Tribolet, A C Diserens, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Anticancer Research|January 1, 1983
Reactivity of antiglioma monoclonal antibodies for a large panel of cultured gliomas and other neuroectoderm derived tumorsB de Muralt, N de Tribolet, A C Diserens, et al.
Respiratory Medicine|June 8, 2001
Is continuous transcutaneous monitoring of PCO2 (TcPCO2) over 8 h reliable in adults?J P Janssens, E Perrin, I Bennani, et al.
European Journal of Cancer & Clinical Oncology|February 1, 1985
Phenotyping of 60 cultured human gliomas and 34 other neuroectodermal tumors by means of monoclonal antibodies against glioma, melanoma and HLA-DR antigensB de Muralt, N de Tribolet, A C Diserens, et al.
Pageof 2